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APP anterograde transport requires Rab3A GTPase activity for
assembly of the transport vesicle
Abstract
The amyloid precursor protein (APP) is anterogradely transported by conventional kinesin in a distinct
transport vesicle, but both the biochemical composition of such a vesicle and the specific kinesin-1
motor responsible for transport are poorly defined. APP may be sequentially cleaved by beta- and
gamma-secretases leading to accumulation of beta-amyloid (Abeta) peptides in brains of Alzheimer's
disease patients, whereas cleavage of APP by alpha-secretases prevents Abeta generation. Here, we
demonstrate by time-lapse analysis and immunoisolations that APP is a cargo of a vesicle containing the
kinesin heavy chain isoform kinesin-1C, the small GTPase Rab3A, and a specific subset of presynaptic
protein components. Moreover, we report that assembly of kinesin-1C and APP in this vesicle type
requires Rab3A GTPase activity. Finally, we show cleavage of APP in transport vesicles by
alpha-secretase activity, likely mediated by ADAM10. Together, these data indicate that maturation of
APP transport vesicles, including recruitment of conventional kinesin, requires Rab3 GTPase activity.
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Theamyloidprecursorprotein (APP) isanterogradely transportedbyconventionalkinesin inadistinct transportvesicle,butboth thebiochem-
ical compositionof suchavesicleandthespecifickinesin-1motorresponsible for transportarepoorlydefined.APPmaybesequentially cleaved
by- and-secretases leading to accumulation of-amyloid (A) peptides in brains of Alzheimer’s disease patients, whereas cleavage of APP
by -secretases prevents A generation. Here, we demonstrate by time-lapse analysis and immunoisolations that APP is a cargo of a vesicle
containing the kinesin heavy chain isoform kinesin-1C, the small GTPase Rab3A, and a specific subset of presynaptic protein components.
Moreover,we report that assembly of kinesin-1C andAPP in this vesicle type requiresRab3AGTPase activity. Finally, we showcleavage ofAPP
intransportvesiclesby-secretaseactivity, likelymediatedbyADAM10.Together, thesedataindicatethatmaturationofAPPtransportvesicles,
including recruitment of conventional kinesin, requires Rab3GTPase activity.
Introduction
The amyloid precursor protein (APP) is a type I transmembrane
protein undergoing processing through sequential cleavage by
either -secretase, including ADAM10 or ADAM17 (ADAM: a
disintegrin andmetalloproteinase), or-secretase BACE1 (-site
APP cleaving enzyme 1) and a proteolytic complex termed
-secretase (Selkoe, 2001; Reinhard et al., 2005).-Amyloid (A)
peptides, which accumulate in brains of Alzheimer’s disease pa-
tients, are produced by the sequential activities of BACE1 and
-secretase. Initial studies speculated that APP is rapidly trans-
ported in a membranous axonal organelle that also contains
BACE1 and -secretase and that these proteases promoted APP
proteolysis within transport vesicles during transit along the axon
(Kamal et al., 2001). In contrast, others reported that Presenilin1
(PS1) and BACE1 have transport kinetics distinct from those of
APP (Lazarov et al., 2005; Goldsbury et al., 2006).
Anterograde transport of APP is clearly mediated by conven-
tional kinesin (kinesin, kinesin-1) (Koo et al., 1990; Ferreira et al.,
1992; Amaratunga et al., 1993; Simons et al., 1995; Tienari et al.,
1996) with velocities of up to 10 m/s (Kaether et al., 2000;
Stamer et al., 2002; Goldsbury et al., 2006) in a vesicle type mor-
phologically distinct from that of synaptophysin-containing
vesicles (Kaether et al., 2000). However, the precise mode of
connecting conventional kinesin with APP-containing trans-
port vesicles remains controversial, and various models have
been proposed. Based on immunoprecipitation experiments
(Kamal et al., 2000) and fast axonal transport (FAT) studies in
squid axoplasm (Satpute-Krishnan et al., 2006), a direct interac-
tion of the APP C terminus with kinesin light chains (KLCs) was
proposed. Inomata et al. (2003) later reported that the interaction
between APP and KLCs might be mediated by c-Jun N-terminal
kinase-interacting protein 1b (JIP1b). However, more recent
data showed that knockdown of JIP1b did not affect localization
of APP at the distal end of neurites (Kins et al., 2006) and that
KLCs do not interact directly with the cytoplasmic tail of APP
(Lazarov et al., 2005), arguing against an essential role of the APP
C terminus and JIP1b in the anterograde transport of APP.More-
over, heterologously expressed APP lacking the C-terminal intra-
cellular domain continued to be transported anterogradely along
the axon, indicating that the C terminus of APP was not required
for anterograde FAT (Tienari et al., 1996; Torroja et al., 1999;
Back et al., 2007; Rusu et al., 2007). Together, these data argue
that APP does not interact directly with conventional kinesin but
do not indicate how conventional kinesin mediates anterograde
APP transport. Using biochemical and live cell imaging ap-
proaches, we show unequivocally that the APP C terminus is not
essential for anterograde FAT of APP. Moreover, our data indi-
cate that Rab3A GTPase activity is required for assembly of
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kinesin-1C, APP, and ADAM10 in a FAT vesicle of unique bio-
chemical composition.
Materials andMethods
cDNA cloning and plasmids. Green fluorescent protein (GFP), human
APP695 cDNA, or APP695 lacking its C terminus (APPCT; amino acids
1-649) fused toGFP, red fluorescentprotein (RFP)or ahemagglutinin (HA)
tag were cloned by PCR-based mutagenesis into pCDNA3.1 (Invitrogen).
Phosphorylated enhanced green fluorescent protein–synaptophysin and
phosphorylated enhanced cyan fluorescent protein (CFP)–synapto-
physin were kind gifts from C. Kaether (Leibniz Institute for Age Re-
search, Jena, Germany) and T. Dresbach (Institute for Anatomy and Cell
Biology, Heidelberg, Germany). pcDNA–Rab3A/B/C/D wild-type and
mutant Q81L constructs were a kind gift from M. Zerial (Max Planck
Institute of Molecular Cell Biology and Genetics, Dresden, Germany).
Phosphorylated cytomegalovirus (pCMV)–myc–Rab3GAP p130 and
pCMV–myc–Rab3GAP p150 were constructed as described previously
(Naganoetal., 1998).Forgenerationof shorthairpinRNA(shRNA)constructs,
synthetic sense and antisense shRNA-oligos were annealed and then cloned
into pKD (Dharmacon) by Sma1/EcoR1. The following oligos were
used: human Rab3GAP p130, sh-sense oligo, GGAACTACTTCAACA-
GATATCAAGAGATATCTGTTGAAGTAGTTCCTTTTTGGGAACTAC-
TTCAACAGATATCAAGAGATATCTGTTGAAGTAGTTCCTTTTTG;
human Rab3GAP p130, sh-antisense oligo, AATTCAAAAAGGAACT-
ACTTCAACAGATATCTCTTGATATCTGTTGAAGTAGTTCCA-
ATTCAAAAAGGAACTACTTCAACAGATATCTCTTGATATCTGTTG-
AAGTAGTTCC; human Rab3GAP p150, sh-sense oligo, ATAT-
GTCTGTCTCCATGTATCAAGAGATACATGGAGACAGACATATTT-
TTTGATATGTCTGTCTCCATGTATCAAGAGATACATGGAGACA-
GACATATTTTTTG; human Rab3GAP p150, sh-antisense oligo,
AATTCAAAAAATATGTCTGTCTCCATGTATCTCTTGATACATGGA-
GACAGACATATAATTCAAAAAATATGTCTGTCTCCATGTATCTCT-
TGATACATGGAGACAGACATAT. Small interfering RNAs (siRNAs) tar-
geting mouse Rab3GAP p130 were purchased from Invitrogen.
Antibodies. Primary antibodies directed against APP C terminus (CT20)
(Calbiochem),APPNterminus (22C11) (Weidemannetal., 1989;Hilbichet
al., 1993), ADAM10 (Calbiochem), ADAM17 (Calbiochem), BACE1 (Cal-
biochem), bassoon (Synaptic Systems), cortactin (Millipore Corporation),
GAP43 (Sigma), GFP (Sigma, Santa Cruz Biotechnology), Grp78 (Stress-
gen), HA epitope (Roche), KDEL (Stressgen), kinesin-1 (H2) (Pfister et al.,
1989), kinesin-1A (PA1-642; Affinity Bioreagents), kinesin-1B (UIC81 se-
rum) (DeBoer et al., 2008),Munc13-1 (Synaptic Systems),Munc18 (Synap-
ticSystems),mycepitope (Sigma),N-Cadherin (SantaCruzBiotechnology),
Nicastrin (Millipore Bioscience Research Reagents), Piccolo (Synaptic Sys-
tems), PS1 (SantaCruzBiotechnology),Rab3 (Synaptic Systems),Rab3GAP
p130 and Rab3GAP p150 (Sakane et al., 2006), RIM2 (Synaptic Systems),
SNAP25 (Synaptic Systems), synapsin-I (BioTrend), synaptophysin
(Sigma), syntaxin-1B (Sigma), and Trk (Sigma). Secondary anti-mouse or
anti-rabbit antibodies used for immunocytochemical orWestern blot anal-
yses were conjugated to Alexa Fluor 488 or 594 (heavy and light chain)
(Invitrogen) or HRP (Promega), respectively.
Live cell time-lapse microscopy and kymograph analysis. Fluorescence
microscopy of living cells transiently expressing fluorescent fusion pro-
teins (16–18 h after transfection) was performed on a Nikon TE2000-E
equippedwith a 60PlanapoVCnumerical aperture (NA) 1.45 or aCarl
Zeiss Axiovert 200M Inverted Microscope equipped with a 100 Carl
Zeiss NA 1.45 microscope. Images were recorded with a Hamamatsu
Orca AG camera using NIS-Elemens software 3.2 (Nikon) or Meta-
Morph Imaging System (Universal ImagingCorporation). Dual-channel
time-lapse (CFP/GFP, RFP) was performed with fast excitation and
emission filter wheels (Lambda 10-2; Sutter Instruments). Cells were
kept at 37°C with a stage top-heating chamber (Tokai Hit). For kymo-
graph analyses, images were captured every 200 ms for a maximum of 2
min.Manual and automatic tracking, velocity analyses, and kymographs
were generated by the use of themultiple kymograph function of theNIH
ImageJ software or MetaMorph Imaging System (Universal Imaging
Corporation). The slope of the traces is a direct measure for the velocity
of the vesicles [v cotan(), where  is the angle relative to the x-axis].
Single tracks with an angle 0  90° were defined as anterograde, and
tracks with a slope 90°  180° were defined as retrograde transport
vesicles. Tracks with slopes of 90° (parallel to the time axis) were deter-
mined as stationary vesicles. The SEM was calculated, and a two-tailed t
test was used for statistical significance determination.
Cell culture. SH-SY5Y cells (American Type Culture Collection number
CRL-2266) were cultivated in 50% MEM, 50% nutrient mixture F-12,
Ham’s medium, 1% MEM nonessential amino acids, 1% L-glutamine, 1%
penicillin/streptomycin, and 15% fetal calf serum (FCS). Mouse primary
neurons were isolated and cultured as described previously (Kuan et al.,
2006). Mouse neuroblastoma N2a cells were cultivated inMEM, 1%MEM
nonessential amino acids, 1% L-glutamine, 1% penicillin/streptomycin, 1%
sodium pyruvate, and 10% FCS. For time-lapse microscopy and immuno-
cytochemical analysis, SH-SY5Y cells and primary neurons were grown on
poly-L-lysine (Sigma)-treated coverslips (Marienfeld). SH-SY5Y cells and
mixedcortical primaryneurons [day in vitro1 (DIV1)orDIV7] frommouse
embryos (embryonicday14)were transfectedusingLipofectaminePlus (In-
vitrogen) or Lipofectamine 2000 (Invitrogen), respectively, as described by
the manufacturer.
Subcellular fractionation of brain membrane vesicles. Wild-type mice
(129Sv  C57BL6 Fx; 129OLA  C57BL/6 Fx; C57BL/6) and APP
knock-out mice (129OLAC57BL/6 Fx) (Li et al., 1996b) were used for
the isolation of membrane and vesicle preparations, as described previ-
ously (DeBoer et al., 2008).Mouse brains were homogenized in4 vol of
ice-cold HOM buffer (300 mM sucrose, 10 mM HEPES, pH 7,4, 5 mM
EDTA, and 1:25 protease inhibitor cocktail) with a glass Teflon homog-
enizer and centrifuged for 5 min at 1200 g, 5000 g, and 10,000 g
(for brain homogenate) and at 100,000  g for 30 min (Sorvall S45A
rotor). The membranes were underloaded on a linear gradient (5–23%
iodixanol inHOMbuffer) (OptiPrep) and centrifuged at 150,000 g for
90 min. Fifteen equal fractions were either collected and analyzed or
pooled light density vesicle fractions (fractions 1–5) were used as starting
material for immunoisolation experiments.
Immunoisolation and immunoprecipitation. Antibodies directed
against APP (CT20) and kinesin-1 (H2) were crosslinked to anti-mouse
or anti-rabbit IgG M-280 magnetic beads (Dynal/Invitrogen) using di-
methyl pimelinediimidate dihydrochloride (DMP) (Fluka) or dithiobis
succinimidyl propionate (Pierce) according to the instructions of the
manufacturer.
Whole-brain homogenates or iodixanol gradient-purified membrane
fractions were incubated with CT20-coupled magnetic beads for 4–12 h
at 4°C. After extensive washing, the immunoisolates were treated with
either 1% (v/v) Nonidet P-40 (NP-40) (Fluka) or chlamidopropyl
dimethylammonio-1-propane-sulfonate (CHAPS) (Sigma) in PBS at
4°C for 30 min or directly heated (5 min, 95°C) in loading buffer. The
supernatants of detergent-treated samples were discarded. The beads were
denatured in loadingbuffer (Kuanet al., 2006)andsubjected toWesternblot
analyses.
For sequential immunoisolations, brain membrane fractions were in-
cubated with CT20-coupled magnetic beads as described above. After
washing, the beads were treated with PBS containing 250 mMDTT over-
night at 4°C. Eluted membranes were diluted (sixfold) in PBS and then
incubated with H2-coupled magnetic beads for 4 h at 4°C. Finally, APP/
kinesin-1 double immunoisolated membranes were processed forWest-
ern blot analyses.
For -secretase inhibition experiments, a membrane permeable zinc-
specific chelator [N,N,N,N-tetrakis-(2-pyridylmethyl)-ethylenediamine
(TPEN)] (Sigma)wasaddedat a concentrationof10Mdirectly aftermouse
brain homogenization for the entire purification procedure (Fonte et al.,
2001).
Immunocytochemistry. SH-SY5Y cells andmixed cortical primary neu-
ronswere grownonpoly-L-lysine (Sigma)-coated coverslips (Marienfeld) in
24-well plates (Falcon) and fixed with 4% paraformaldehyde (Sigma) for
30 min, permeabilized for 10 min in PBS with 0.1% NP-40, and blocked
in PBS with 5% (v/v) goat serum (Sigma) for 1 h. After incubation with
primary and secondary antibodies, the coverslips were embedded in
Mowiol (Sigma) and analyzed by fluorescence microscopy (60 objec-
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tive, FITC or cyanine 5 filters) as described in
detail previously (Kuan et al., 2006).
Results
Anterograde fast axonal transport
of APP is independent of its
intracellular domain
Immunocytochemical and immunohisto-
logical analyses of APP lacking the C ter-
minus (APPC) in primary neurons and
Drosophila motor neurons revealed that
APP undergoes anterograde FAT in the
absence of its C terminus (Tienari et al.,
1996; Torroja et al., 1999; Back et al., 2007;
Rusu et al., 2007). However, these experi-
ments did not examine whether APP an-
terograde FAT rates might be altered by
deletion of the APP C-terminus, nor did
they evaluate whether APP and APPCT
are cotransported in the same type of ves-
icles. To address these issues, we per-
formed live microscopy studies of GFP
fusion proteins with APP (APP–GFP) and
APP lacking the C terminus (APPCT–
GFP) in primary neurons. Mixed cortical
neurons (DIV7) were transfected with
cDNAs encoding either APP–GFP or
APPCT–GFP and analyzed by time-
lapse microscopy 18 h after transfection
(Fig. 1A–C). Velocity analysis revealed
that APP–GFP is transported with a max-
imal velocity of 7–10 m/s (Fig. 1)
(supplemental Fig. 1, available at www.
jneurosci.org as supplemental material),
consistent with previous studies (Kaether
et al., 2000; Goldsbury et al., 2006).
Detailed analyses of APP–GFP and
APPCT–GFP transport rates (Fig. 1D)
revealed that APPCT–GFP movement
was indistinguishable from full-length APP–GFP, arguing that
the APP C terminus is not required for packaging of APP in the
anterograde transport vesicles or docking of conventional ki-
nesin. To determine whether APP and APPCT are trans-
ported in the same type of vesicles, we cotransfected primary
neurons with APP–RFP and APPCT–GFP. The two fluorescent
proteins were visualized sequentially with a time interval of 200
ms (exposure time and time for changing the filter).We observed
that anterograde movements of both fusion proteins were highly
correlated. After tracking anterogradely transported vesicles, ve-
locity kinetics were determined. This analysis revealed identical
trafficking characteristics for APP–RFP andAPPCT–GFP (sup-
plemental Fig. 1B, available at www.jneurosci.org as supplemen-
tal material), indicating that they were cotransported in the same
type of vesicle. Consistent with previous studies (Kaether et al.,
2000), we found that synaptophysin–CFP was transported in a
different type of transport vesicle from APP–RFP and APPCT–
GFP (data not shown), indicating that heterologously expressed
APP fusion proteins are targeted to a specific type of transport
vesicles. Recently, we reported that APP forms homotypic cis-
dimers (Soba et al., 2005). To exclude the possibility that
APPCT–GFP might be cotransported by associating to endog-
enous APP, we used primary neurons from APP knock-out mice
transfected with APPCT–GFP for time-lapse analysis. These
studies showed that the FAT machinery transports APPCT–
GFP even in the absence of endogenous APP (supplemental
Fig. 1A, available at www.jneurosci.org as supplemental mate-
rial). Consistently, analysis of APP–GFP and APPCT–GFP
transport inAPP/APLP1/APLP2 triple-knock-outmouse embry-
onic fibroblasts revealed no differences of their fast transport
characteristics (1–4 m/s) (data not shown). Together, these
data suggest that the APP C terminus is not required for FAT of
APP.
APP is a cargo of a kinesin-1C associated transport vesicle
Previous studies indicated that APP-containing vesicles are
transported by conventional kinesin. The holoenzyme of con-
ventional kinesin exists as a tetramer consisting of two KLCs and
two kinesin heavy chain (kinesin-1, KHC, KIF5s) subunits
(DeBoer et al., 2008). Following the standard nomenclature
for kinesins, the term “conventional kinesin” herein refers to
the tetrameric motor protein complex (heavy and light chains),
whereas “kinesin-1” refers exclusively to the heavy chain subunits
(Lawrence et al., 2004; DeBoer et al., 2008). To identify specific
kinesin-1 isoform(s) linked to APP-containing vesicles and char-
acterize the APP cargo vesicle, we performed immunoisolations
from crude mouse brain membrane fractions, using magnetic
beads loaded with an antibody directed against the C terminus of
APP (CT20-coupled beads). APP immunoisolates were analyzed by
Figure 1. APP can be transported by the fast axonal transport machinery in the absence of its intracellular C terminus. Mouse
primary cortical neurons (DIV7) expressing APP–GFP and/or APPCT–GFP were analyzed by time-lapse microscopy 18 h after
transfection.A, Fluorescencemicrographs of APP–GFP- and APPCT-GFP-expressing neurons. For tracking and velocity analyses,
a region of interest (red box) was selected. Sequential images of the region of interest are shown to the right. Colored arrowheads
indicate the single vesicles that have been examined. Time interval between images was 200 ms, 5 images/s. B, Representative
kymographs showing APP–GFP and APPCT-GFP movement. C, Velocities of APP–GFP- and APPCT-GFP-containing vesicles,
assayed over a period of 22 s.D, Histogram showing quantification of the number of recorded vesicles moving at velocities of 1, 2,
3, 4, 5, or6m/s. No statistical significant differences between the velocities of APP–GFP- and APPCT-containing transport
vesicles could be determined (Student’s t test, p 0.2). Scale bar, 25m.
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immunoblotting using antibodies that specifically recognize differ-
entkinesin-1geneproducts: kinesin-1A,kinesin-1B, andkinesin-1C
[formerly KIF5A, KIF5B, and KIF5C, respectively (Lawrence et al.,
2004)] (DeBoer et al., 2008) (Fig. 2A). No immunoreactivity was
detected with an antibody against kinesin-1B (specific antibodies
used are described inMaterials andMethods), and barely detectable
amounts of kinesin-1A were present in the APP immunoisolates.
The anti-kinesin-1 antibody (H2) reacting with both kinesin-1A
and kinesin-1C (DeBoer et al., 2008) displayed significant immu-
noreactivity when reacted with APP immunoisolated fractions (Fig.
2A). TheH2 immunoreactive band in theAPP immunoisolatesmi-
grated at a significant lower molecular weight than kinesin-1A and
could therefore be clearly identified as
kinesin-1C (DeBoer et al., 2008). Thus,
conventional kinesin associated with
APP-containing membranes is mainly
composed of kinesin-1C. Specificity of the
kinesin-1C immunoreactivity in APP im-
munoisolates was verified using brain ho-
mogenates from APP knock-out mice (Fig.
2A). In the absence of endogenous APP, we
did not observe nonspecific binding of any
kinesin-1 isoform to immunoisolates ob-
tained with the CT20-loaded magnetic
beads (Fig. 2A).
APP can be associated with a variety of
membrane structures, including Golgi,
endoplasmic reticulum (ER), and trans-
port vesicles (Kins et al., 2006). To enrich
for membrane fractions containing ax-
onal transport vesicles, we separated the
brain extracts in a linear iodixanol gradi-
ent (5–23%). We thus obtained low-
densitymembranematerial enriched with
presynaptic marker proteins such as GAP43,
synapsin-IA/B, and synaptophysin (supple-
mental Fig. 2, available at www.jneurosci.
org as supplemental material). Thesemem-
branes were mostly separated from ER or
cis-Golgi membrane fractions, as evidenced
by low levels of typical ER and cis-Golgi
markers (anti-Grp78 and anti-KDEL). Sig-
nificantly, APP immunoisolates obtained
from pooled membrane fractions 1–5 from
wild-type mouse brains also contained
kinesin-1C (Fig. 2B). As before (Fig. 2A),
immunoisolatesprepared fromAPPknock-
outmousebraincontainednokinesin-1 im-
munoreactivity and served as negative
controls (Fig. 2B). Treatment of the APP-
immunoisolated membranes with deter-
gents (i.e., 1% NP-40 or 15 mM CHAPS)
caused a loss of kinesin-1C from APP
immunoisolates (Fig. 2B). In contrast,
treatment of immunoisolates with con-
centrations of CHAPS (1.5mM) below the
critical micellar concentration (Kratohvil,
1984; Partearroyo et al., 1988) did not
cause a dissociation of kinesin-1C from
APP beads (Fig. 2B). Crosslinking of APP
immunoisolates with DMP before treat-
ment with detergent did not maintain
the APP/kinesin interaction (data not
shown). Combined with the live cell analyses of transport of APP
lacking the C terminus, these data suggest that conventional ki-
nesin containing kinesin-1C heavy chains associates with APP
transport vesicles in a manner independent of the APP C
terminus.
Characterization of APP transport vesicles
To characterize APP-containingmembrane compartmentsmov-
ing in FAT (i.e., transport vesicles) in more detail, we performed
two sequential immunoisolations with CT20 and H2-loaded
magnetic beads. APP-containingmembrane compartments were
prepared as described previously using beads linked with a disul-
Figure 2. APP is a cargo of an axonal transport vesicle containing presynaptic components and is associatedwith kinesin-1C.A,
Immunoisolations (IS) of APP using an anti-APP antibody (CT20) fromwild-type (wt) and APP knock-out (APP/) mouse brain
homogenates. Each lysate (1⁄80)was loadedas input control (Input).Western blot analyses of APP immunoisolateswith antibodies
against specific kinesin-1s revealed that APP is mainly associated with kinesin-1C. B, Immunoisolated APP containingmembrane
preparations fromwild-typemice (wt)were treatedwith 1% (v/v) NP-40 (lane 3), 15mMCHAPS (lane 4), 1.5mMCHAPS (below the
criticalmicellar concentration) (lane 5), or no detergent (lane 1). An immmunoisolate using anti-APP antibody obtained fromAPP
knock-out mice (APP/) is shown as a control (lane 2). C, Total mouse brain membrane fractions were separated on a linear
iodixanol gradient (supplemental Fig. 2, available at www.jneurosci.org as supplemental material), and low-density membrane
fractions (fractions 1–5) were pooled and used for a two-step immunoisolation: vesicles were first immunoisolated with an
anti-APP antibody (IS:APP). After these, immunoisolated membranes were eluted and subject to immunoisolation with an anti-
kinesin-1 antibody (H2) (IS: APP/kinesin-1) (for details, see Materials and Methods). Coimmunoisolated proteins were separated
by SDS-PAGE and subjected to Western blot analysis. Brain homogenates from APP knock-out (APP/) mice were used for
immunoisolation with anti-APP antibody as a control for nonspecific binding. To test for specificity of anti-kinesin-1 immunoiso-
lations, a non-immune IgG fraction (IgG) was used (IS:APP/IgG).
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fide crosslinker to CT20 antibodies. CT20 immunoisolates were
then treated with DTT to elute APP-containing membranes and
subjected to a second round of immunoisolation using H2-
loaded magnetic beads, allowing for the enrichment of mem-
branes containing both APP and kinesin-1C.
Double APP/kinesin-1-immunoisolated membrane prepara-
tions were subjected to Western blot analysis, using various
antibodies directed against a wide range of presynaptic and
postsynaptic protein components. Only a subset of presynaptic
proteins was detected in these APP/kinesin-1C double immu-
noisolates, including SNARE complex components (such as
VAMP2, SNAP25, and syntaxin-1b) and synapsin-I, as well as
components of the active zone, such as Rab3, RIM2, Munc13-1,
and Rab3GAP p130 and p150 (Fig. 2C). Other presynaptic com-
ponents previously described as putative cargoes of APP trans-
port vesicles, including GAP43 and TrkA (Kamal et al., 2001),
were not found in our membrane immunoisolates. Synaptophy-
sin, a presynaptic protein previously shown to be transported in a
different class of membranous organelles than APP (Kaether et
al., 2000), was also absent. Neither postsynaptic proteins, such as
the NMDAor AMPA receptor (data not shown), nor presynaptic
cytomatrix proteins (Dresbach et al., 2001), such as bassoon and
piccolowere detected inAPP/kinesin-1Cdouble immunoisolates
(Fig. 2C). To control for specificity of the double immunoiso-
lates, we used membrane preparations from APP knock-out
mouse brain in the first APP immunoisolation step. Specificity of
the kinesin-1 immunoisolation was verified by using non-
immune mouse Ig (Fig. 2C).
Immunoisolation experiments here show that APP/kinesin-1
coimmunoisolated membrane fractions contain a subset of pre-
synaptic protein contents that included syntaxin, synapsin-I,
Rab3, and several Rab3A associated proteins but did not include
synaptophysin or typical protein components of the active zone,
such as bassoon or piccolo. Together, these data strongly suggest
that APP and other presynapticmembrane protein represent car-
goes present in a biochemically distinct presynapticmembranous
organelle, which in turn associates primarily with kinesin-1C.
APP localization at growth cones depends on Rab3A
GTPase activity
Interestingly, some of the components identified in APP trans-
port vesicles (i.e., Rab3GAP p130, Rab3GAP p150) are known to
interact with and to stimulate the GTPase activity of Rab3 family
members (Rab3A–Rab3D) (Fukui et al., 1997; Sakane et al.,
Figure 3. Rab3-subtype-specific influence on APP localization. To determine specific Rab3 family members that might be essential for anterograde transport of APP, we tested the influence of
both wild-type (wt) and GTPase-deficient mutant (Q81L) versions of GFP-tagged Rab3A–Rab3D on APP-HA localization at the distal end of growing neurites. Neuroblastoma cells (SH-SY5Y) were
cotransfected with the different Rab3 constructs together with APP-HA cDNA and analyzed by immunocytochemistry using anti-GFP (red), anti-HA (green), and as a growth cone marker
anti-cortactin (cyan) antibodies. Notably, only transfectionwith the Rab3AQ81L construct caused a reduction in the level of APP that normally accumulates at the distal ends of neurites. To visualize
the neurites more clearly, the regions of interest (boxed) are shown at higher magnification in the two right columns. Scale bar, 10m. Higher-magnification bar, 3.3m.
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2006). APP typically accumulates at the distal end of neurites
(Ferreira et al., 1993; Morfini et al., 1997; Sabo et al., 2003), and
inhibition of anterograde APP transport affects this accumula-
tion (Ferreira et al., 1992; Morfini et al., 1997). We cotransfected
neuroblastoma SH-SY5Y cells with APP–HA and specific Rab3
isoforms (Rab3A–Rab3D) and then examined accumulation of
APP–HA at the growth cones of neurites (identified by costaining
with the growth cone marker cortactin). Rab3 constructs used in
these experiments included wild-type forms or GTPase-deficient
mutants carrying a Q81L amino acid replacement (Johannes et
al., 1994) (kind gifts fromM. Zerial) (Fig. 3B). Significantly, only
coexpression of the Rab3A GTPase-deficient mutant caused a
reduction of APP levels at the neurite ends, suggestive of a deficit
in the anterograde transport of APP. None of the other wild-type
or mutant Rab3 isoforms altered APP distributions in SH-SY5Y
cells (Fig. 3). These findings suggested that Rab3A GTPase ac-
tivity is required for anterograde FAT of APP.
Rab3A GTPase activity is essential for
fast anterograde transport of APP
As an independent test of the hypothesis
that Rab3AGTPase activity is required for
APP anterograde transport, we knocked
down Rab3GAP p130 and Rab3GAP p150
in SH-SY5Y cells using shRNA con-
structs. Western blot analysis showed a
40–60% reduction inRab3GAPp130 lev-
els (Fig. 4B). Because the transfection ef-
ficiency with the vector-based shRNA
constructs was 50–60%, the knockdown
efficiency per transfected cell was esti-
mated to be70–80%. Rab3GAP knock-
down cells expressingAPP–GFP exhibited
accumulation of APP in the cell soma, and
APP–GFP failed to accumulate in neurite
ends (Fig. 4A). In contrast, mock-trans-
fected cells exhibited the typical APP–
GFP accumulations at neurite ends (Fig.
4A). Notably, overexpression of Rab3GAPs
p130 and p150 together with APP led to a
more pronounced accumulation of APP
at the growing tips (supplemental Fig. 3,
available at www.jneurosci.org as supple-
mental material). To characterize the role
of Rab3A GTPase activity in anterograde
transport of APP further, we transfected
SH-SY5Y cells with either the Rab3A
Q81L mutant construct or with shRNA
constructs directed against Rab3GAP
p130 and p150. Cells were analyzed by
time-lapse microscopy (5 frames/s) 18 h
after APP–GFP cDNA transfection. APP–
GFP-expressing cells cotransfected with
empty vector (Fig. 4C, white column) or
wild-type Rab3A coexpressing cells served
as controls (data not shown). To evaluate
changes in APP transport rates, we calcu-
lated the relative frequencies of stationary
(0.2 m/s), retrogradely (0.2 m/s),
and anterogradely (0.2 m/s) trans-
ported APP–GFP-containing vesicles in
12 or more individual cotransfected cells
for each construct tested. In neurites of
control vector-transfected cells, we found
in distal regions 41 	 7% (mean 	 SEM) stationary, 30 	 5%
(mean	 SEM) retrogradely, and 29	 2% (man	 SEM) antero-
gradely transported APP–GFP vesicles (Fig. 4C). The relative fre-
quencies of anterograde transport vesicles were significantly
reduced after inhibition of Rab3A GTPase activity with the
Rab3AQ81Lmutant (14%) or silencing of Rab3GAPp130 (12%)
or Rab3GAP p150 (16%) (t test, p  0.001) (Fig. 4C), but fre-
quencies of retrogradely transported and stationary membrane
compartmentswere not significantly altered (Fig. 4C). These data
indicate that Rab3A GTPase activity modulated fast anterograde
transport of APP. To make sure that inhibition of Rab3A GTPase
does not cause a general block of anterograde FAT, we evaluated
FAT of synaptophysin-containing vesicles, which is carried in a dif-
ferent cargovesicle thanAPP(Kaether et al., 2000) (Fig. 4C).Neither
mutant Rab3A Q81L nor silencing of Rab3GAP p130 or p150 af-
fected the relative frequencies of synaptophysin–GFP vesicles found
Figure 4. Rab3 GTPase activity is essential for APP fast anterograde transport. Neuroblastoma cells (SH-SY5Y) were
cotransfected with APP–GFP cDNA and empty vector (mock), Rab3A Q81L cDNA, shRNA constructs directed against
Rab3GAP p130, or Rab3GAP p150. A, Mock-transfected cells expressing APP–GFP displayed an accumulation of APP–GFP at
the tips of neurites (box), whereas inhibition of Rab3A GTPase activity by expression of mutant Rab3A Q81L or silencing of
Rab3GAP p130 or p150 caused a decrease of APP–GFP levels at the tips. Differential interference contrast images of the
regions of interest/of the indicated regions (boxed) are shown as insets. Scale bar, 10 m. B, The silencing efficiency of
the human Rab3GAP p130 or Rab3GAP p150 shRNA was of40 – 60%. Taking into account that the transfection rate with
the vector-based shRNA constructs was 50 – 60%, the knockdown efficiency per transfected cell was estimated to be
70 – 80%. GAPDH, Glyceraldehyde-3-phosphate dehydrogenase. C, APP–GFP (left) or synaptophysin–GFP (right) fusion
proteins were analyzed by time-lapse microscopy (5 frames/s) in mock-transfected neuroblastoma cells (white columns),
cells coexpressing Rab3A Q81L (black columns), or cells with knockdown [RNA interference (RNAi)] of Rab3GAP p130 (dark
gray columns) or Rab3GAP p150 (light gray columns). Kymographs from single cells (n 12) were analyzed. The relative
frequencies of stationary, retrogradely, or anterogradely transported APP–GFP (left) or synaptophysin–GFP (right) con-
taining vesicles was determined. The range of velocities for synaptophysin–GFP (syn) is lower (1–5m/s) than the range
seen with APP (1–10 m/s). Therefore, we determined only the relative frequency of anterograde APP–GFP vesicles
moving at velocities4m. Error bars represent SEM. ***p 0.001, t test.
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in anterograde or retrograde FAT, sug-
gesting that inhibition of Rab3A GTPase
specifically affects the anterograde FAT
of APP-containing vesicles. Together, these
findings suggest thatRab3AGTPase activity
is required for anterograde FAT of APP.
We also investigated the effects of
Rab3GAPp130 knockdownonAPP local-
ization using primary cultured neurons.
We treated stage 1 primary neurons with
Rab3GAP p130 siRNA and analyzed the
localization of endogenous APP (Fig. 5B).
Treatment with Rab3GAP p130 siRNA
caused a statistical significant reduction of
Rab3GAP p130 levels to 64	 9%. As ob-
served in SH-SY5Y cells, a clear reduction
of APP accumulation at the tips of neu-
rites was seen in primary neurons treated
with the Rab3GAP p130 siRNA construct
compared with control transfected cells
(Fig. 5B,C). For quantification, we mea-
sured the intensity of GFP–APP in the cell
body and the tip of neurites of single cells
treated with control or Rab3GAP p130
siRNA (n  27 for each) (Fig. 5C). Con-
sistent with data obtained from SH-SY5Y
cells, the ratio of GFP–APP intensity at
tips/cell bodies was reduced by 40% in
Rab3GAP p130 siRNA-treated cells com-
pared with control treated cells. Silencing
of Rab3GAP p130 caused a reduction of
APP intensity at the tips and an accumu-
lation of APP in the cell bodies, suggesting
that Rab3A GTPase activity is also re-
quired for anterograde FAT of APP in pri-
mary neurons.
The activities of Rab3GAP p130 and
p150 are required for the attachment
of conventional kinesin to
APP-containing vesicles
Given that Rab3 GTPase activity is required for the anterograde
FAT of APP, we speculated that conversion of Rab3A fromGTP-
to-GDP bound states might be crucial for the correct assembly of
APP transport vesicles. To test this possibility, we used isolated
membranes from Rab3GAP p130 knock-out mice, which display
reduced levels of Rab3A activity (Sakane et al., 2006). Signifi-
cantly, the amounts of kinesin-1, Rab3, and the Rab3 associated
proteins RIM2 and Munc13-1 were dramatically decreased in
APP immunoisolates derived from Rab3GAP p130 knock-out
brains compared with immunoisolates derived from wild-type
mouse brain (Fig. 6). Regarding the activity-dependent associa-
tion of Rab3A with membranes, this appears consistent with the
reduction in Rab3A activity reported in brains of p130/
knock-out mice (Sakane et al., 2006). Together, these data indi-
cate that Rab3AGTPase activity is required for the correct assem-
bly of APP into anterograde transport vesicles, including the
packaging of membrane proteins, such as Rab3A, and the associ-
ation of the motor protein conventional kinesin.
APP and ADAM10 are cargoes of a common transport vesicle
In this study, we identified several novel putative cargo proteins
present in APP-containing transport vesicles. The question of
Figure 5. Inhibition of Rab3 GTPase activity reduces the levels of APP at the tips of neurites. Mouse primary cortical
neurons (DIV1) were transfected with siRNA directed against Rab3GAP p130 or nonfunctional control siRNA. A, Western
blot analysis indicated that the silencing effect of mouse Rab3GAP p130 was35%. B, Immunocytochemistry of the siRNA
transfected stage 1 primary neurons using antibody directed against the APP C terminus (CT20) reveals that the cells
treated with Rab3GAP p130 siRNA have less APP accumulation at the tips of neurites. For clarity, the tips of the neurites
(boxed) are shown at a higher magnification as inset. C, For quantification, the intensity of APP in the cell body and in the
tip of the neurites was measured using NIH ImageJ. The ratio of APP intensity at tips/cell bodies was reduced40% in cells
treated with Rab3GAP p130 siRNA compared with control siRNA transfected cells. Error bars represent SEM. *p 0.01,
t test. Scale bar, 5m.
Figure 6. Loss of kinesin-1 from APP transport vesicles in Rab3GAP p130 knock-out
mice. Low-density membrane fractions from wild-type (wt) or Rab3GAP p130 knock-out
mouse (p130/) brain homogenates were immunoisolated with anti-APP antibodies
(IS:APP) and subjected to Western blot analyses using antibodies directed against
Rab3GAP p130, Rab3GAP p150, kinesin-1, Rab3, and two putative cargoes of APP trans-
port vesicles, RIM2 and Munc13-1 (see Fig. 1). Total lysate (1⁄80) from each brain was
loaded in the lanes of the left panel as input control (Input).
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whether the APP-processing secretases BACE1 and PS1 are also
cargo proteins in these vesicles has been controversial (Kamal et
al., 2001; Lazarov et al., 2005; Goldsbury et al., 2006). To clarify
this issue, we performed APP/kinesin-1 double immunoisola-
tions as described above and examined the presence of APP secre-
tases and APP processing in the isolated membrane fractions. In
Western blot analysis of APP/kinesin-1 double immunoisolates
from mouse brain homogenates, neither BACE1 nor PS1 were
detectable (Fig. 7A). Nicastrin, another component of
-secretase, was also undetectable in APP/kinesin-1 double im-
munoisolates (Fig. 7A). We also tested for the presence of the
putative -secretases ADAM10 and ADAM17. From these, only
ADAM10 was detected in double immunoisolates obtained from
wild-type, but not from APP knock-out, mouse brain, suggesting
thatAPP/kinesin-1 double-immunoisolatedmembrane compart-
ments contain ADAM10 as a cargo protein.
Next, we evaluatedAPP processing in the isolatedAPP transport
vesicle fraction. For this purpose, we probed APP/kinesin-1 double
immunoisolateswith an antibody directed against theAPPN termi-
nus [22C11, which recognizes both full-length APP and cleaved,
secretedAPP(sAPP)] andwithanantibodydirectedagainst theAPP
C terminus (CT20, which recognizes full-length APP but not sAPP)
(Fig. 7B). These analyses revealed a clear difference in the detected
patternofAPP immunoreactivity.The22C11antibody recognized a
lower-molecular-weight band, not detected by the C-terminal anti-
body, representing sAPP. To exclude nonspecific cross-reactivity of
the 22C11 antibody, we tested the antibody on brain extracts of
wild-type andAPP knock-outmice. No immunoreactivity was seen
with the 22C11 antibody in APP knock-out mice (data not
shown). To test whether APP can be cleaved by -secretase in
the APP/kinesin-1 double-immunoisolated membrane com-
partment, we treated the double-immunoisolated membrane
fractions over a time period of30 h with a membrane-permeable
zinc chelator (10MTPEN) that inhibits-secretase activity (Fonte
et al., 2001). The generation of the lower-molecular-weight putative
sAPP band was reduced in the presence of
the -secretase inhibitor. Together, these
data suggest that APP might be pro-





The APP C terminus is not essential for
fast anterograde transport
A role of APP as a cargo receptor for con-
ventional kinesin has been a contentious
issue (Kamal et al., 2000, 2001; Lazarov et
al., 2005). Various reports proposed that
transport of APP-containing vesicles de-
pends on a direct interaction between the
C terminus of APP and the KLCs of con-
ventional kinesin, suggesting that APP
acts as a motor protein adaptor/receptor
(Kamal et al., 2000). Contrasting with
predictions from this model, we and oth-
ers showed that APP constructs lacking
the C-terminal intracellular domain are
transported to the nerve terminal (Tienari
et al., 1996; Torroja et al., 1999; Back et al.,
2007; Rusu et al., 2007). However, it was
unclear whether the anterograde FAT of
APP lacking its C terminus was mediated
bymechanisms different from those underlying transport of full-
length APP. In this study, time-lapse analyses of fluorescently
labeled APP demonstrates that APP lacking its C terminus is
packed and transported in the same type of FAT vesicles as
full-length APP. Treatment of APP/kinesin-1 coimmunoisolated
membranes with detergents caused the dissociation of kinesin-1
from the APP-immunoisolated membranes, arguing against a
direct interaction between these proteins. Together, our data
demonstrate that APP is a cargo of a specific subset of mem-
branes transported by conventional kinesin and not a receptor
protein directly linking conventional kinesin via its C termi-
nus to this vesicle type. However, additional analyses will be
necessary to determine the molecular basis underlying the as-
sociation of conventional kinesin with APP transport vesicles.
As with many integral membrane proteins, a fraction of the
APP is returned by retrograde transport (Lazarov et al., 2007,
their Fig. 1). Our analysis of APP–GFP transport included prox-
imal dendrites. Because themicrotubule cytoskeleton in this area
is not uniformly organized (microtubules may exhibit both po-
larities), conventional kinesin-dependent transport can take
place in both directions (retrogradely and anterogradely relative
to the cell body). However, the presence of some APP in the
endosomal compartments (Ferreira et al., 1993) is consistent
with retrograde FAT.
Kinesin-1Cmediates axonal transport of APP
Based on studies of APP transport after treatment with antisense
oligos directed against kinesin-1B, it was assumed that APP an-
terograde transport is mediated by kinesin-1B (Ferreira et al.,
1992; Kaether et al., 2000). However, in these studies, neither a
specific reduction of kinesin-1B nor analyses of other kinesin-1
isoforms were performed. Here, we tested systematically for
kinesin-1 family members (kinesin-1A, kinesin-B, kinesin-C)
thatmight be selectively associatedwithAPP-containingmembrane
Figure 7. APP and ADAM10 are cargoes of a common transport vesicle. A, Western blot analyses of APP/kinesin-1 double
immunoisolates (IS:APP/kinesin-1) with anti-ADAM10, anti-ADAM17, anti-BACE1, anti-PS1, and anti-Nicastrin antibodies. As
control for APP/kinesin-1 double immunoisolations, brain homogenates from APP knock-out mice (APP/) and non-immune
IgGs (IS:IgG) were used. Each lysate (1⁄80) was loaded as input control (Input). wt, Wild type. B, Western blot analyses of APP/
kinesin-1 double-immunoisolated membrane preparations (IS:APP/kinesin-1) with an antibody directed against the APP N ter-
minus (22C11), recognizing full-length (fl.) APP (arrowhead) and cleaved sAPP (asterisk), as well as an antibody directed against
the APP C terminus, recognizing full-length APP (CT20) but not sAPP. TPEN, a zinc chelator blocking -secretase activity, was
added directly after brain homogenization at a concentration of 10M when indicated (
).
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fractions. Interestingly, we found that
kinesin-1B was not detectable in APP im-
munoisolates, but kinesin-1C (and to a
much lesser extent, kinesin-1A) is preferen-
tially associatedwithAPP transport vesicles.
Recently, itwas shown that conventional ki-
nesin holoenzymes are formed of kinesin-1
homodimers, which associate with bio-
chemically different cargoes (DeBoer et
al., 2008). The selective association of
APP-containing transport vesicles with
kinesin-1C reported here appears consis-
tent with a role of kinesin-1s in the target-
ing of conventional kinesin holoenzymes
to specific membrane-bounded organelle
cargoes (DeBoer et al., 2008).
A presynaptic transport vesicle subtype
contains both Rab3A and APP
Our detailed biochemical characteriza-
tion of APP transport vesicles in associ-
ation with kinesin-1C revealed that
these membrane compartments con-
tained no postsynaptic protein contents
but instead contained a subset of pre-
synaptic proteins, including synapsin-I,
SNAP25, syntaxin-1B,VAMP2,Munc13-1,
RIM2, Rab3, and Rab3GAP p130 and
p150. Significantly, all these protein car-
goes are involved in various aspects of
synaptic vesicle fusion. Thus, our results
here are consistent with previous studies
suggesting that APPmay play a role in the
regulation of vesicle fusion and synaptic function (Wang et al.,
2005; Yang et al., 2007).
Rab3A was shown previously to be present in several different
presynaptic vesicle types along with various other proteins,which
are transported by different velocities along the ax including
syntaxin-1, SNAP25, bassoon, piccolo, Munc18, N-Cadherin,
and VAMP2 (Okada et al., 1995; Zhai et al., 2001), which are
transported by different velocities along the axon (Shapira et
al., 2003). Likely, APP transport vesicles represent only a subset of
the cargo proteins that can be cotransported with Rab3A. Our
data suggest that Rab3A may be involved in the packaging of
specific proteins into different vesicle subtypes that in turn may be
movedbyspecificmotorproteins. In this regard, it is remarkable that
inhibition of Rab3A had no influence on the anterograde transport
of synaptophysin, although Rab3 colocalizes with synaptophysin at
nerve terminals (Li et al., 1996a), and has been copurified from syn-
aptic vesicles in immunoisolation experiments (Fischer vonMollard
et al., 1990; deWit et al., 1999).Theanti-Rab3antibodyused in these
two studies does not allow differentiating between the Rab3 iso-
forms. Thus, the apparent discrepancy between these studies and
our analysesmight be explainedby the fact that synaptophysin is not
a cargo of vesicles containing Rab3A but possibly a cargo of Rab3B–
Rab3D-containingvesicles.Alternatively,Rab3Aandsynaptophysin
may be packaged in a common vesicle after they have reached the
nerve terminal indistinct transport vesicles, as suggestedbyprevious
immunoisolation studies (Okada et al., 1995). Consistent with this
latter possibility, some components of the APP transport vesicle
have been found in association with synaptic vesicle fractions
(synapsin-I, syntaxin-1, SNAP25, etc.), although APP has not been
found as a component of synaptic vesicles (Takamori et al., 2006).
Rab3A GTPase activity is required for APP transport
By using a Rab3A GTPase-deficient mutant and by silencing of
Rab3GAP p130 or p150, we showed that conversion of Rab3A-GTP
to Rab3A-GDP is essential for anterograde FAT transport of APP in
neuronal cells. These findings are consistent with previous experi-
ments in isolated axoplasm indicating that FAT depends on the
activity of small GTPases (Bloomet al., 1993). Rab3GTPase family
members are key regulators of presynaptic vesicular transport with
overlapping, but not identical, functions (Burstein et al., 1993;
Deneka et al., 2003; Schluter et al., 2004; Ali and Seabra, 2005;
Star et al., 2005). After delivery to their respectivemembranes, Rabs
are activated by replacement of GDP byGTP. GTP-bound Rabs are
thought to orchestrate the assembly of cargo contents, motor asso-
ciation, and docking interactions between donor and target mem-
branes, whereas Rab3-GDP is presumably generated during or after
exocytosis, allowingRab3release fromthe targetmembrane(Fischer
vonMollard et al., 1991; Stahl et al., 1994; Sakisaka et al., 2002; Star et
al., 2005). Recent data, however, showed that Rab3A knockdown,
knock-out, or overexpression of GTP-lockedmutant Rab3A signif-
icantly decreases the number of vesicles docked at the plasmamem-
brane without altering the kinetics of individual exocytotic events
(Schluter et al., 2006; Tsuboi and Fukuda, 2006; Coleman et al.,
2007; Handley et al., 2007; vanWeering et al., 2007). Together with
these studies, our data argue that Rab3A does not play an essential
role in vesicle fusion but rather in the transport of vesicles to the
plasmamembrane. Inaddition,our studies suggest thatRab3A-GTP
hydrolysis might take place before the vesicle docks to the target
membrane.
The well established role of Rabs in protein sorting led us to
examine alterations in the composition of APP-containingmem-
Figure 8. Model of APP anterograde transport vesicle assembly. Data presented here suggest that, in neurons, APP is
sorted into an FAT vesicle containing Rab3A and other presynaptic components. 1, In the first step (likely in the late Golgi
apparatus), the GTP-bound form of Rab3A (red circle) mediates packaging and assembly of APP and a specific set of
presynaptic components (i.e., syntaxin-1, SNAP25, synapsin-1, Munc13-1, and RIM2) in a common vesicle. 2, After this,
Rab3A-GTP hydrolysis catalyzed by dimerized Rab3GAP p130 and p150 (yellow rectangle) causes a conformational change
of Rab3A-GTP (red circle) to Rab3A-GDP (red square), accompanied by recruitment of a specific kinesin-1 isoform variant
(kinesin-1C) to the APP transport vesicle. 3, Finally, the assembled FAT vesicle is transported by this conventional kinesin
via microtubule tracks to its target membrane at the presynaptic terminal, in which the APP transport vesicle fuses with the
presynaptic acceptor membrane.
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brane cargoes induced by reduced Rab3A activity. Significantly,
we found reduced levels of kinesin-1C and other protein cargoes
in APP-containing membranous organelles obtained from
p130/mouse brain, in which Rab3A GTPase activity is inhib-
ited. Together, our findings suggest a model in which Rab3
GTPase activity is required for correct assembly of APP and other
membrane proteins (i.e., syntaxin-1, SNAP25, and synapsin-I) in
a biochemically distinct transport vesicle type. In addition, our
results suggest that Rab3A may regulate the association of
kinesin-1C to the APP transport vesicle (Fig. 8).
APP can be cleaved by-secretase in transport vesicles
The subcellular compartment and spatial regulation of APP pro-
cessing secretases, such as ADAM10, ADAM17, BACE1, or PS1,
remains to be determined, because this information is critical for
understanding the biology of APP. Early suggestions that BACE1
and PS1 are cotransported with APP in anterogradely trans-
ported axonal vesicles (Kamal et al., 2001) were not confirmed in
subsequent studies (Lazarov et al., 2005; Goldsbury et al., 2006).
Our studies here found that APP/kinesin-1-immunoisolated
membrane fractions did not contain detectable levels of
ADAM17, BACE1, PS1, or Nicastrin. Of the secretase compo-
nents examined, only ADAM10 was detected in these membrane
preparations. Remarkably, sAPP was detected in the isolated
membrane fractions after in vitro incubations. Generation of this
sAPP was blocked by a zinc chelator/inhibitor of -secretase,
consistent with the possibility that -secretase activity is present
in the immunoisolated organelle fractions. However, compared
with full-length APP, the amount of sAPP was 1%, indicating
that only low amounts of sAPP might be generated on its way to
the plasma membrane. Alternatively, the process of immunoiso-
lation may lead to activation of associated ADAM10. The physi-
ological significance of this processing in immunoisolated
vesicles remains to be determined, but therapeutic strategies af-
fecting APP packaging in transport vesiclesmight help reduce A
generation.
Together, our data suggest a novel, Rab3A-dependent mech-
anism for the coordinated regulation of APP sorting and axonal
transport events, giving important insights into the physiological
and pathogenic function of APP.
References
Ali BR, SeabraMC (2005) Targeting of RabGTPases to cellularmembranes.
Biochem Soc Trans 33:652–656.
Amaratunga A, Morin PJ, Kosik KS, Fine RE (1993) Inhibition of kinesin
synthesis and rapid anterograde axonal transport in vivo by an antisense
oligonucleotide. J Biol Chem 268:17427–17430.
Back S, Haas P, Tscha¨pe JA, Gruebl T, Kirsch J, Mu¨ller U, Beyreuther K, Kins
S (2007) beta-amyloid precursor protein can be transported indepen-
dent of any sorting signal to the axonal and dendritic compartment.
J Neurosci Res 85:2580–2590.
Bloom GS, Richards BW, Leopold PL, Ritchey DM, Brady ST (1993) GTP
gamma S inhibits organelle transport along axonal microtubules. J Cell
Biol 120:467–476.
Burstein ES, BrondykWH, Macara IG, Kaibuchi K, Takai Y (1993) Regula-
tion of the GTPase cycle of the neuronally expressed Ras-like GTP-
binding protein Rab3A. J Biol Chem 268:22247–22250.
Coleman WL, Bill CA, Bykhovskaia M (2007) Rab3a deletion reduces vesi-
cle docking and transmitter release at the mouse diaphragm synapse.
Neuroscience 148:1–6.
DeBoer SR, You Y, Szodorai A, Kaminska A, Pigino G, Nwabuisi E, Wang B,
Estrada-Hernandez T, Kins S, Brady ST, Morfini G (2008) Conven-
tional kinesin holoenzymes are composed of heavy and light chain ho-
modimers. Biochemistry 47:4535–4543.
de Wit H, Lichtenstein Y, Geuze HJ, Kelly RB, van der Sluijs P, Klumperman
J (1999) Synaptic vesicles form by budding from tubular extensions of
sorting endosomes in PC12 cells. Mol Biol Cell 10:4163–4176.
DenekaM, Neeft M, van der Sluijs P (2003) Regulation of membrane trans-
port by rab GTPases. Crit Rev Biochem Mol Biol 38:121–142.
Dresbach T, Qualmann B, Kessels MM, Garner CC, Gundelfinger ED (2001)
The presynaptic cytomatrix of brain synapses. Cell Mol Life Sci 58:94–116.
Ferreira A, Niclas J, Vale RD, Banker G, Kosik KS (1992) Suppression of
kinesin expression in cultured hippocampal neurons using antisense oli-
gonucleotides. J Cell Biol 117:595–606.
Ferreira A, Caceres A, Kosik KS (1993) Intraneuronal compartments of the
amyloid precursor protein. J Neurosci 13:3112–3123.
Fischer von Mollard G, Mignery GA, Baumert M, Perin MS, Hanson TJ,
Burger PM, Jahn R, Su¨dhof TC (1990) rab3 is a small GTP-binding
protein exclusively localized to synaptic vesicles. ProcNatl Acad Sci U S A
87:1988–1992.
Fischer von Mollard G, Su¨dhof TC, Jahn R (1991) A small GTP-binding
protein dissociates from synaptic vesicles during exocytosis. Nature
349:79–81.
Fonte J, Miklossy J, Atwood C, Martins R (2001) The severity of cortical
Alzheimer’s type changes is positively correlated with increased amyloid-
beta levels: resolubilization of amyloid-beta with transition metal ion
chelators. J Alzheimers Dis 3:209–219.
Fukui K, Sasaki T, Imazumi K, Matsuura Y, Nakanishi H, Takai Y (1997)
Isolation and characterization of a GTPase activating protein specific for
the Rab3 subfamily of small G proteins. J Biol Chem 272:4655–4658.
Goldsbury C, Mocanu MM, Thies E, Kaether C, Haass C, Keller P, Biernat J,
Mandelkow E, Mandelkow EM (2006) Inhibition of APP trafficking by
tau protein does not increase the generation of amyloid-beta peptides.
Traffic 7:873–888.
Handley MT, Haynes LP, Burgoyne RD (2007) Differential dynamics of
Rab3A and Rab27A on secretory granules. J Cell Sci 120:973–984.
Hilbich C, Mo¨nning U, Grund C, Masters CL, Beyreuther K (1993)
Amyloid-like properties of peptides flanking the epitope of amyloid pre-
cursor protein-specific monoclonal antibody 22C11. J Biol Chem
268:26571–26577.
Inomata H, Nakamura Y, Hayakawa A, Takata H, Suzuki T, Miyazawa K,
Kitamura N (2003) A scaffold protein JIP-1b enhances amyloid precur-
sor protein phosphorylation by JNK and its association with kinesin light
chain 1. J Biol Chem 278:22946–22955.
Johannes L, Lledo PM, RoaM, Vincent JD, Henry JP, Darchen F (1994) The
GTPase Rab3a negatively controls calcium-dependent exocytosis in neu-
roendocrine cells. EMBO J 13:2029–2037.
Kaether C, Skehel P, Dotti CG (2000) Axonal membrane proteins are trans-
ported in distinct carriers: a two-color videomicroscopy study in cultured
hippocampal neurons. Mol Biol Cell 11:1213–1224.
Kamal A, StokinGB, Yang Z, Xia CH,Goldstein LS (2000) Axonal transport
of amyloid precursor protein is mediated by direct binding to the kinesin
light chain subunit of kinesin-I. Neuron 28:449–459.
Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein LS (2001)
Kinesin-mediated axonal transport of a membrane compartment con-
taining beta-secretase and presenilin-1 requires APP. Nature
414:643–648.
Kins S, Lauther N, Szodorai A, Beyreuther K (2006) Subcellular trafficking
of the amyloid precursor protein gene family and its pathogenic role in
Alzheimer’s disease. Neurodegener Dis 3:218–226.
Koo EH, Sisodia SS, Archer DR, Martin LJ, Weidemann A, Beyreuther K,
Fischer P, Masters CL, Price DL (1990) Precursor of amyloid protein in
Alzheimer disease undergoes fast anterograde axonal transport. ProcNatl
Acad Sci U S A 87:1561–1565.
Kratohvil JP (1984) Size of bile salt micelles: techniques, problems and re-
sults. Hepatology 4:85S–97S.
Kuan YH, Gruebl T, Soba P, Eggert S, Nesic I, Back S, Kirsch J, Beyreuther K,
Kins S (2006) PAT1a modulates intracellular transport and processing
of APP, APLP1 and APLP2. J Biol Chem 281:40114–40123.
Lawrence CJ, Dawe RK, Christie KR, Cleveland DW, Dawson SC, Endow SA,
Goldstein LS, Goodson HV, Hirokawa N, Howard J, Malmberg RL,
McIntosh JR, Miki H, Mitchison TJ, Okada Y, Reddy AS, Saxton WM,
Schliwa M, Scholey JM, Vale RD, Walczak CE, Wordeman L (2004) A
standardized kinesin nomenclature. J Cell Biol 167:19–22.
LazarovO,Morfini GA, Lee EB, FarahMH, Szodorai A, DeBoer SR, Koliatsos
VE, Kins S, Lee VM, Wong PC, Price DL, Brady ST, Sisodia SS (2005)
Axonal transport, amyloid precursor protein, kinesin-1, and the process-
ing apparatus: revisited. J Neurosci 25:2386–2395.
Lazarov O, Morfini GA, Pigino G, Gadadhar A, Chen X, Robinson J, Ho H,
Szodorai et al. • APP Transport Vesicle Assembly Requires Rab3A J. Neurosci., November 18, 2009 • 29(46):14534–14544 • 14543
Brady ST, Sisodia SS (2007) Impairments in fast axonal transport and
motor neuron deficits in transgenic mice expressing familial Alzheimer’s
disease-linked mutant presenilin 1. J Neurosci 27:7011–7020.
Li JY, Jahn R, HouXE, Kling-Petersen A, Dahlstro¨mA (1996a) Distribution
of Rab3a in rat nervous system: comparison with other synaptic vesicle
proteins and neuropeptides. Brain Res 706:103–112.
Li ZW, StarkG,Go¨tz J, Ru¨licke T,GschwindM,HuberG,Mu¨llerU,Weissmann
C (1996b) Generation of mice with a 200-kb amyloid precursor protein
gene deletion by Cre recombinase-mediated site-specific recombination in
embryonic stem cells. Proc Natl Acad Sci U S A 93:6158–6162.
Morfini G, Quiroga S, Rosa A, Kosik K, Ca´ceres A (1997) Suppression of KIF2
in PC12 cells alters the distribution of a growth cone nonsynapticmembrane
receptor and inhibits neurite extension. J Cell Biol 138:657–669.
Nagano F, Sasaki T, Fukui K, Asakura T, Imazumi K, Takai Y (1998)
Molecular cloning and characterization of the noncatalytic subunit of
the Rab3 subfamily-specific GTPase-activating protein. J Biol Chem
273:24781–24785.
Okada Y, Yamazaki H, Sekine-Aizawa Y, Hirokawa N (1995) The neuron-
specific kinesin superfamily protein KIF1A is a uniquemonomericmotor
for anterograde axonal transport of synaptic vesicle precursors. Cell
81:769–780.
PartearroyoMA,Gon˜i FM,Katime I, AlonsoA (1988) Micellar properties of
the zwitterionic bile derivative CHAPS. Biochem Int 16:259–265.
Pfister KK, Wagner MC, Stenoien DL, Brady ST, Bloom GS (1989) Mono-
clonal antibodies to kinesin heavy and light chains stain vesicle-like struc-
tures, but not microtubules, in cultured cells. J Cell Biol 108:1453–1463.
ReinhardC,He´bert SS,De Strooper B (2005) The amyloid-beta precursor pro-
tein: integrating structure with biological function. EMBO J 24:3996–4006.
Rusu P, Jansen A, Soba P, Kirsch J, Lo¨wer A, Merdes G, Kuan YH, Jung A,
Beyreuther K, Kjaerulff O, Kins S (2007) Axonal accumulation of synaptic
markers in APP transgenic Drosophila depends on the NPTY motif and is
paralleled by defects in synaptic plasticity. Eur J Neurosci 25:1079–1086.
Sabo SL, Ikin AF, Buxbaum JD, Greengard P (2003) The amyloid precursor
protein and its regulatory protein, FE65, in growth cones and synapses in
vitro and in vivo. J Neurosci 23:5407–5415.
Sakane A, Manabe S, Ishizaki H, Tanaka-Okamoto M, Kiyokage E, Toida K,
Yoshida T,Miyoshi J, KamiyaH, Takai Y, Sasaki T (2006) Rab3GTPase-
activating protein regulates synaptic transmission and plasticity through
the inactivation of Rab3. Proc Natl Acad Sci U S A 103:10029–10034.
Sakisaka T, Meerlo T, Matteson J, Plutner H, Balch WE (2002) Rab-
alphaGDI activity is regulated by a Hsp90 chaperone complex. EMBO J
21:6125–6135.
Satpute-Krishnan P, DeGiorgis JA, Conley MP, JangM, Bearer EL (2006) A
peptide zipcode sufficient for anterograde transport within amyloid pre-
cursor protein. Proc Natl Acad Sci U S A 103:16532–16537.
Schlu¨ter OM, Schmitz F, Jahn R, Rosenmund C, Su¨dhof TC (2004) A
complete genetic analysis of neuronal Rab3 function. J Neurosci
24:6629–6637.
Schlu¨ter OM, Basu J, Su¨dhof TC, Rosenmund C (2006) Rab3 superprimes
synaptic vesicles for release: implications for short-term synaptic plastic-
ity. J Neurosci 26:1239–1246.
Selkoe DJ (2001) Alzheimer’s disease: genes, proteins, and therapy. Physiol
Rev 81:741–766.
Shapira M, Zhai RG, Dresbach T, Bresler T, Torres VI, Gundelfinger ED, Ziv
NE, Garner CC (2003) Unitary assembly of presynaptic active zones
from Piccolo-Bassoon transport vesicles. Neuron 38:237–252.
Simons M, Ikonen E, Tienari PJ, Cid-Arregui A, Mo¨nning U, Beyreuther K,
Dotti CG (1995) Intracellular routing of human amyloid protein pre-
cursor: axonal delivery followed by transport to the dendrites. J Neurosci
Res 41:121–128.
Soba P, Eggert S,Wagner K, Zentgraf H, Siehl K, Kreger S, Lo¨wer A, Langer A,
Merdes G, Paro R, Masters CL, Mu¨ller U, Kins S, Beyreuther K (2005)
Homo- and heterodimerization of APP family members promotes inter-
cellular adhesion. EMBO J 24:3624–3634.
Stahl B, von Mollard GF, Walch-Solimena C, Jahn R (1994) GTP cleavage by
the small GTP-binding proteinRab3A is associatedwith exocytosis of synap-
tic vesicles induced by alpha-latrotoxin. J Biol Chem 269:24770–24776.
Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM (2002) Tau
blocks traffic of organelles, neurofilaments, and APP vesicles in neurons
and enhances oxidative stress. J Cell Biol 156:1051–1063.
Star EN, Newton AJ, Murthy VN (2005) Real-time imaging of Rab3a and
Rab5a reveals differential roles in presynaptic function. J Physiol
569:103–117.
Takamori S, HoltM, Stenius K, Lemke EA, GrønborgM, Riedel D, UrlaubH,
Schenck S, Bru¨gger B, Ringler P, Mu¨ller SA, Rammner B, Gra¨ter F, Hub
JS, De Groot BL, Mieskes G, Moriyama Y, Klingauf J, Grubmu¨ller H,
Heuser J, Wieland F, Jahn R (2006) Molecular anatomy of a trafficking
organelle. Cell 127:831–846.
Tienari PJ, De Strooper B, Ikonen E, Simons M, Weidemann A, Czech C,
Hartmann T, Ida N, Multhaup G, Masters CL, Van Leuven F, Beyreuther
K, Dotti CG (1996) The beta-amyloid domain is essential for axonal
sorting of amyloid precursor protein. EMBO J 15:5218–5229.
Torroja L, Packard M, Gorczyca M, White K, Budnik V (1999) The Dro-
sophila beta-amyloid precursor protein homolog promotes synapse dif-
ferentiation at the neuromuscular junction. J Neurosci 19:7793–7803.
Tsuboi T, Fukuda M (2006) Rab3A and Rab27A cooperatively regulate the
docking step of dense-core vesicle exocytosis in PC12 cells. J Cell Sci
119:2196–2203.
van Weering JR, Toonen RF, Verhage M (2007) The role of Rab3a in secre-
tory vesicle docking requires association/dissociation of guanidine phos-
phates and Munc18–1. PLoS ONE 2:e616.
Wang P, Yang G, Mosier DR, Chang P, Zaidi T, Gong YD, Zhao NM,
Dominguez B, Lee KF, Gan WB, Zheng H (2005) Defective neuromus-
cular synapses inmice lacking amyloid precursor protein (APP) andAPP-
Like protein 2. J Neurosci 25:1219–1225.
Weidemann A, Ko¨nig G, Bunke D, Fischer P, Salbaum JM, Masters CL,
Beyreuther K (1989) Identification, biogenesis, and localization of pre-
cursors of Alzheimer’s disease A4 amyloid protein. Cell 57:115–126.
Yang L, Wang B, Long C, Wu G, Zheng H (2007) Increased asynchronous
release and aberrant calcium channel activation in amyloid precursor
protein deficient neuromuscular synapses. Neuroscience 149:768–778.
Zhai RG, Vardinon-Friedman H, Cases-Langhoff C, Becker B, Gundelfinger
ED, Ziv NE, Garner CC (2001) Assembling the presynaptic active zone:
a characterization of an active one precursor vesicle. Neuron 29:131–143.
14544 • J. Neurosci., November 18, 2009 • 29(46):14534–14544 Szodorai et al. • APP Transport Vesicle Assembly Requires Rab3A
